Compare TRIP & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIP | AHG |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Business Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2011 | 2017 |
| Metric | TRIP | AHG |
|---|---|---|
| Price | $7.25 | $1.35 |
| Analyst Decision | Hold | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $11.46 | N/A |
| AVG Volume (30 Days) | ★ 6.0M | 6.4K |
| Earning Date | 11-05-2026 | 07-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 675.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,556,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.78 | $0.68 |
| 52 Week High | $15.73 | $2.50 |
| Indicator | TRIP | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 36.41 | 50.91 |
| Support Level | $6.78 | $1.14 |
| Resistance Level | $10.04 | $1.46 |
| Average True Range (ATR) | 0.55 | 0.07 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 10.45 | 50.56 |
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025. The company is selling TheFork, its dining brand, which represented 12% of sales.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.